Empagliflozin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
2023 · The Lancet Diabetes & Endocrinology · 36 citations
https://doi.org/10.1016/s2213-8587(23)00253-x
N
N Harris
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
15
Papers
113
Citations
4
h-index
3
i10-index
N Harris is an academic researcher from Moffitt Cancer Center. The author has contributed to research in topics: COVID-19 Clinical Research Studies & SARS-CoV-2 and COVID-19 Research & Retinal Diseases and Treatments. The author has an h-index of 4, co-authored 13 publications.
Papers by this author
worksImmunomodulatory therapy in children with paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS, MIS-C; RECOVERY): a randomised, controlled, open-label, platform trial
2024 · The Lancet Child & Adolescent Health · 33 citations
https://doi.org/10.1016/s2352-4642(23)00316-4
Molnupiravir or nirmatrelvir–ritonavir plus usual care versus usual care alone in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
2025 · The Lancet Infectious Diseases · 5 citations
https://doi.org/10.1016/s1473-3099(25)00093-3
Higher dose corticosteroids in hospitalised COVID-19 patients requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial
2025 · EClinicalMedicine · 3 citations
https://doi.org/10.1016/j.eclinm.2025.103080
Sotrovimab versus usual care in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
2025 · The Lancet Infectious Diseases · 0 citations
https://doi.org/10.1016/s1473-3099(25)00361-5
Postoperative Impact of Closed Incision Negative Pressure Therapy Following Oncoplastic Breast Surgery
2025 · Annals of Surgical Oncology · 0 citations
https://doi.org/10.1245/s10434-025-18738-z
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat